VEGFA and hepatocellular carcinoma: Interestingly, this immunological contribution in the predictive potential of cfDNA in the ICB regimens is coherent with the higher informativity of cfDNA versus ctDNA detection in the study that evaluated the ability of these molecules to predict response and prognosis in HCC patients treated with PD-L1 + VEGF inhibitors.